Skip to main content
. 2022 Mar 6;11(3):350. doi: 10.3390/antibiotics11030350

Table 4.

Summary of findings table with comparison between octenidine and saline solution in chronic wound care.

Comparison Three: Octenidine Compared to Saline for Chronic Wound Care
Patient or Population: Chronic Wound Care
Intervention: Octenidine
Comparison: Saline
Outcomes Anticipated Absolute Effects * (95% CI) Relative Effect (95% CI) № of Participants (Studies) Certainty of the Evidence (GRADE)
Risk with Saline Risk with Octenidine
Wound healing assessed with: Proportion of patients with complete wound healing follow-up: mean 12 weeks 242 per 1000 250 per 1000
(136 to 461)
RR 1.0313
(0.5595 to 1.9009)
126
(1 RCT)
⨁⨁⨁⨁
HIGH
Adverse events assessed with: AE report follow-up: mean 12 weeks 317 per 1000 178 per 1000
(90 to 351)
RR 0.5614
(0.2844 to 1.1081)
120
(1 RCT)
⨁⨁⨁⨁
HIGH
Healing rate assessed with: planimetry follow-up: mean 12 weeks No difference in the healing rate of the patients in the octenidine group, compared to patients in the saline group (37.9% vs. 40.3%; p = 0.769) [29]. (1 RCT) ⨁⨁⨁⨁
HIGH
Pain assessment—not measured Not reported - -
GRADE Working Group grades of evidence
⨁⨁⨁⨁ High certainty: We are very confident that the true effect lies close to that of the estimate of the effect.
⨁⨁⨁ Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.
⨁⨁ Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect.

* The risk in the intervention group (and 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and 95% CI). CI: confidence interval; RR: risk ratio; RCT: randomised controlled trial.